PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development
April 05, 2022 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug...